Cargando…
Inflammation and incretins
Nutrient excess results in systemic inflammation in diabetes contributing to insulin resistance, dyslipidaemia and increased cardiovascular risk. GLP-1 agonists and DPP-4 inhibitors, which are now well accepted therapies for diabetes may play a unique role in modulating this inflammatory process. In...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603036/ https://www.ncbi.nlm.nih.gov/pubmed/23565388 http://dx.doi.org/10.4103/2230-8210.104049 |
_version_ | 1782263618366078976 |
---|---|
author | Hatwal, Amitabh |
author_facet | Hatwal, Amitabh |
author_sort | Hatwal, Amitabh |
collection | PubMed |
description | Nutrient excess results in systemic inflammation in diabetes contributing to insulin resistance, dyslipidaemia and increased cardiovascular risk. GLP-1 agonists and DPP-4 inhibitors, which are now well accepted therapies for diabetes may play a unique role in modulating this inflammatory process. Incretin based therapies have shown beneficial anti-inflammatory effects on surrogate markers but cardiovascular outcome data is still lacking. |
format | Online Article Text |
id | pubmed-3603036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36030362013-04-05 Inflammation and incretins Hatwal, Amitabh Indian J Endocrinol Metab Mini Review Nutrient excess results in systemic inflammation in diabetes contributing to insulin resistance, dyslipidaemia and increased cardiovascular risk. GLP-1 agonists and DPP-4 inhibitors, which are now well accepted therapies for diabetes may play a unique role in modulating this inflammatory process. Incretin based therapies have shown beneficial anti-inflammatory effects on surrogate markers but cardiovascular outcome data is still lacking. Medknow Publications & Media Pvt Ltd 2012-12 /pmc/articles/PMC3603036/ /pubmed/23565388 http://dx.doi.org/10.4103/2230-8210.104049 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Mini Review Hatwal, Amitabh Inflammation and incretins |
title | Inflammation and incretins |
title_full | Inflammation and incretins |
title_fullStr | Inflammation and incretins |
title_full_unstemmed | Inflammation and incretins |
title_short | Inflammation and incretins |
title_sort | inflammation and incretins |
topic | Mini Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603036/ https://www.ncbi.nlm.nih.gov/pubmed/23565388 http://dx.doi.org/10.4103/2230-8210.104049 |
work_keys_str_mv | AT hatwalamitabh inflammationandincretins |